Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0014 | 0.0494 | 0.5 |
Mycobacterium ulcerans | dehydrogenase | 0.0014 | 0.0494 | 0.5 |
Brugia malayi | hypothetical protein | 0.0014 | 0.0494 | 0.0508 |
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Plasmodium vivax | hypothetical protein, conserved | 0.0014 | 0.0494 | 0.5 |
Leishmania major | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0021 | 0.0846 | 0.0845 |
Plasmodium vivax | protoporphyrinogen oxidase, putative | 0.0014 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase | 0.0014 | 0.0494 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.3809 | 0.3809 |
Loa Loa (eye worm) | hypothetical protein | 0.0077 | 0.4161 | 0.4161 |
Onchocerca volvulus | CoRest homolog | 0.0177 | 1 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0006 | 0 | 0.5 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0014 | 0.0494 | 0.5 |
Schistosoma mansoni | amine oxidase | 0.0014 | 0.0494 | 0.1295 |
Plasmodium vivax | hypothetical protein, conserved | 0.0014 | 0.0494 | 0.5 |
Plasmodium falciparum | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Mycobacterium ulcerans | monoamine oxidase | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.3809 | 0.3809 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Mycobacterium tuberculosis | Possible oxidoreductase | 0.0014 | 0.0494 | 0.5 |
Giardia lamblia | hypothetical protein | 0.0006 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Trypanosoma cruzi | UDP-galactopyranose mutase | 0.0014 | 0.0494 | 0.5 |
Plasmodium vivax | lysine-specific histone demethylase 1, putative | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0172 | 0.9706 | 0.9706 |
Brugia malayi | SWIRM domain containing protein | 0.0077 | 0.4161 | 0.4287 |
Plasmodium falciparum | lysine-specific histone demethylase 1, putative | 0.0014 | 0.0494 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0494 | 0.0493 |
Plasmodium falciparum | conserved Plasmodium protein, unknown function | 0.0014 | 0.0494 | 0.5 |
Toxoplasma gondii | histone lysine-specific demethylase LSD1/BHC110/KDMA1A | 0.0014 | 0.0494 | 1 |
Schistosoma mansoni | amine oxidase | 0.0014 | 0.0494 | 0.1295 |
Mycobacterium ulcerans | flavin-containing monoamine oxidase AofH | 0.0014 | 0.0494 | 0.5 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0014 | 0.0494 | 0.1295 |
Entamoeba histolytica | SWIRM domain protein | 0.0006 | 0 | 0.5 |
Chlamydia trachomatis | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0006 | 0 | 0.5 |
Schistosoma mansoni | Protoporphyrinogen oxidase chloroplast/mitochondrial precursor | 0.0014 | 0.0494 | 0.1295 |
Echinococcus granulosus | lysine specific histone demethylase 1A | 0.0071 | 0.3809 | 1 |
Brugia malayi | Myb-like DNA-binding domain containing protein | 0.0172 | 0.9706 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0014 | 0.0494 | 0.0493 |
Brugia malayi | amine oxidase, flavin-containing family protein | 0.0021 | 0.0846 | 0.0871 |
Echinococcus multilocularis | 0.0014 | 0.0494 | 0.1295 | |
Mycobacterium ulcerans | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.5 |
Schistosoma mansoni | Lysine-specific histone demethylase 1 | 0.0071 | 0.3809 | 1 |
Echinococcus multilocularis | lysine specific histone demethylase 1A | 0.0071 | 0.3809 | 1 |
Echinococcus multilocularis | protoporphyrinogen oxidase | 0.0014 | 0.0494 | 0.1295 |
Mycobacterium leprae | PROBABLE PROTOPORPHYRINOGEN OXIDASE HEMY (PROTOPORPHYRINOGEN-IX OXIDASE) (PROTOPORPHYRINOGENASE) (PPO) | 0.0014 | 0.0494 | 0.5 |
Mycobacterium ulcerans | oxidoreductase | 0.0014 | 0.0494 | 0.5 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.